JP2023542701A5 - - Google Patents
Info
- Publication number
- JP2023542701A5 JP2023542701A5 JP2023519000A JP2023519000A JP2023542701A5 JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5 JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083834P | 2020-09-25 | 2020-09-25 | |
| US63/083,834 | 2020-09-25 | ||
| US202063107196P | 2020-10-29 | 2020-10-29 | |
| US63/107,196 | 2020-10-29 | ||
| US202163238483P | 2021-08-30 | 2021-08-30 | |
| US63/238,483 | 2021-08-30 | ||
| PCT/US2021/051957 WO2022067039A1 (en) | 2020-09-25 | 2021-09-24 | Pharmaceutical formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542701A JP2023542701A (ja) | 2023-10-11 |
| JP2023542701A5 true JP2023542701A5 (https=) | 2024-10-01 |
| JPWO2022067039A5 JPWO2022067039A5 (https=) | 2024-10-01 |
Family
ID=78179552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519000A Pending JP2023542701A (ja) | 2020-09-25 | 2021-09-24 | 薬学的製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230338283A1 (https=) |
| EP (1) | EP4216956A1 (https=) |
| JP (1) | JP2023542701A (https=) |
| KR (1) | KR20230074536A (https=) |
| AU (1) | AU2021347349A1 (https=) |
| CA (1) | CA3196829A1 (https=) |
| IL (1) | IL301596A (https=) |
| MX (1) | MX2023003431A (https=) |
| TW (1) | TW202228691A (https=) |
| WO (1) | WO2022067039A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2561132C2 (ru) | 2009-06-29 | 2015-08-20 | Аджиос Фармасьютикалз, Инк. | Производные хинолинсульфонамидов и их применение для модулирования пкм2 активности |
| FI3307271T3 (fi) | 2015-06-11 | 2023-10-17 | Agios Pharmaceuticals Inc | Pyruvaattikinaasin aktivaattorien käyttämisen menetelmä |
| JP7275130B2 (ja) * | 2017-11-22 | 2023-05-17 | アジオス ファーマシューティカルズ， インコーポレイテッド | Ｎ－（４－（４－（シクロプロピルメチル）ピペラジン－１－カルボニル）フェニル）キノリン－８－スルホンアミドの結晶性形態 |
-
2021
- 2021-09-24 EP EP21791565.1A patent/EP4216956A1/en active Pending
- 2021-09-24 KR KR1020237013787A patent/KR20230074536A/ko active Pending
- 2021-09-24 TW TW110135559A patent/TW202228691A/zh unknown
- 2021-09-24 US US18/028,058 patent/US20230338283A1/en active Pending
- 2021-09-24 MX MX2023003431A patent/MX2023003431A/es unknown
- 2021-09-24 JP JP2023519000A patent/JP2023542701A/ja active Pending
- 2021-09-24 AU AU2021347349A patent/AU2021347349A1/en active Pending
- 2021-09-24 CA CA3196829A patent/CA3196829A1/en active Pending
- 2021-09-24 WO PCT/US2021/051957 patent/WO2022067039A1/en not_active Ceased
- 2021-09-24 IL IL301596A patent/IL301596A/en unknown